ArticleJournal of cell communication and signaling2025
Integrated genomics reveals cellular senescence-driven molecular networks and immune crosstalk in myopia pathogenesis.
Article in Journal of cell communication and signaling, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- DNA Methylation Signatures of Cellular Senescence Are Not Reversed by Senolytic Treatment.Aging cell · 2026Article
- Cellular Biological Basis and Novel Breakthroughs in the Pathogenesis of Myopia - A Narrative Review.International journal of general medicine · 2026Review
- Integrated genomics reveals cellular senescence-driven molecular networks and immune crosstalk in myopia pathogenesis.Journal of cell communication and signaling · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Myopia, a leading global health challenge linked to severe ocular complications, remains poorly understood in terms of molecular mechanisms involving cellular senescence. This study integrates transcriptomic datasets (GSE112155 and GSE151631) from myopia and normal vision samples to unravel senescence-driven pathways and immune interactions underlying myopia pathogenesis. By constructing protein-protein interaction networks and post-transcriptional regulatory axes (mRNA-miRNA-TF), we identified core senescence-associated genes (Tp53, Cdkn1a, and Myc) as central regulators in myopia progression. Single-sample gene set enrichment analysis revealed significant immune dysregulation in myopia, marked by altered infiltration of γδ T cells, natural killer T cells, and neutrophils. Functional validation through Tp53 overexpression and Cdkn1a/Myc knockout in mice demonstrated their critical roles in exacerbating myopia phenotypes, including elongated eye axis and thickened retina. These findings highlight a synergistic interplay between cellular senescence and immune-mediated mechanisms in myopia, supported by multi-omics evidence and in vivo experiments. Our work not only maps the molecular networks bridging senescence and myopia but also proposes novel therapeutic targets for modulating these pathways. This study advances the understanding of myopia as a senescence-associated disorder and underscores the potential of targeting immune-senescence crosstalk for intervention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.